Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Snap-on Inc Director's Dealing 2025

Jun 3, 2025

30335_dirs_2025-06-02_337700f1-f7ef-4a0a-a856-c19e53301876.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2025-06-02

Reporting Person: PINCHUK NICHOLAS T (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-02 Common Stock M 33750 $138.03 Acquired 827681.7678 Direct
2025-06-02 Common Stock S 5798 $314.8056 Disposed 821883.7678 Direct
2025-06-02 Common Stock S 8692 $315.6618 Disposed 813191.7678 Direct
2025-06-02 Common Stock S 8282 $316.6997 Disposed 804909.7678 Direct
2025-06-02 Common Stock S 400 $317.297 Disposed 804509.7678 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-02 Stock Option (Right to Buy) $138.03 M 33750 Disposed 2026-02-11 Common Stock (33750) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 851.0221 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $168.70 2027-02-09 Common Stock (135000) 135000 Direct
Stock Option (Right to Buy) $161.18 2028-02-15 Common Stock (92288) 92288 Direct
Stock Option (Right to Buy) $155.92 2029-02-14 Common Stock (83059) 83059 Direct
Stock Option (Right to Buy) $155.34 2030-02-13 Common Stock (83059) 83059 Direct
Stock Option (Right to Buy) $189.89 2031-02-11 Common Stock (40687) 40687 Direct
Stock Option (Right to Buy) $211.67 2032-02-10 Common Stock (32286) 32286 Direct
Stock Option (Right to Buy) $249.26 2033-02-09 Common Stock (24295) 24295 Direct
Stock Option (Right to Buy) $269.00 2034-02-15 Common Stock (23710) 23710 Direct
Stock Option (Right to Buy) $339.73 2035-02-13 Common Stock (18925) 18925 Direct
Restricted Stock Units $ 2026-02-09 Common Stock (5549) 5549 Direct
Restricted Stock Units $ 2027-02-15 Common Stock (5114) 5114 Direct
Restricted Stock Units $ 2028-02-13 Common Stock (4425) 4425 Direct
Performance Units $ Common Stock (16645) 16645 Direct
Performance Units $ Common Stock (15340) 15340 Direct
Performance Units $ Common Stock (13275) 13275 Direct
Deferred Stock Units $ Common Stock (25718.3186) 25718.3186 Direct

Footnotes

F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.

F2: This transaction was executed in multiple trades at prices ranging from $314.22 to $315.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F3: This transaction was executed in multiple trades at prices ranging from $315.22 to $316.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F4: This transaction was executed in multiple trades at prices ranging from $316.22 to $317.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F5: This transaction was executed in multiple trades at prices ranging from $317.24 to $317.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F6: This information is based on a plan statement dated March 31, 2025.

F7: Option fully vested.

F8: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.

F9: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.

F10: 1 for 1.

F11: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.

F12: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F13: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F14: If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F15: Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.